Evidence map›Paper›PMID 26575624›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses.

Audrey Stéphanie Richard, Adam Zhang, Sun-Jin Park, Michael Farzan, Min Zong, Hyeryun Choe

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 140 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Antiviral agents for dengue virus.Virologica Sinica · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Riding apoptotic bodies for cell-cell transmission by African swine fever virus.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Review

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Audrey Stéphanie RichardThe Scripps Research Institute, Immunology and Microbial Sciences, Jupiter, FL 33458.
Adam ZhangThe Scripps Research Institute, Immunology and Microbial Sciences, Jupiter, FL 33458.
Sun-Jin ParkThe Scripps Research Institute, Immunology and Microbial Sciences, Jupiter, FL 33458.
Michael FarzanThe Scripps Research Institute, Immunology and Microbial Sciences, Jupiter, FL 33458.
Min ZongThe Scripps Research Institute, Immunology and Microbial Sciences, Jupiter, FL 33458.
Hyeryun ChoeThe Scripps Research Institute, Immunology and Microbial Sciences, Jupiter, FL 33458 hchoe@scripps.edu.
Scripps Research Institute · US

Funding

Phosphatidylserine Receptors in Flavivirus InfectionR01AI110692 · NIAID · SCRIPPS FLORIDA · PI CHOE, HYERYUN · 2014 to 2018
$2.4M
NIAID NIH HHS AI110692NIAID NIH HHS R01 AI110692
6 · The paper itself

Abstract

Phosphatidylserine (PS) receptors contribute to two crucial biological processes: apoptotic clearance and entry of many enveloped viruses. In both cases, they recognize PS exposed on the plasma membrane. Here we demonstrate that phosphatidylethanolamine (PE) is also a ligand for PS receptors and that this phospholipid mediates phagocytosis and viral entry. We show that a subset of PS receptors, including T-cell immunoglobulin (Ig) mucin domain protein 1 (TIM1), efficiently bind PE. We further show that PE is present in the virions of flaviviruses and filoviruses, and that the PE-specific cyclic peptide lantibiotic agent Duramycin efficiently inhibits the entry of West Nile, dengue, and Ebola viruses. The inhibitory effect of Duramycin is specific: it inhibits TIM1-mediated, but not L-SIGN-mediated, virus infection, and it does so by blocking virus attachment to TIM1. We further demonstrate that PE is exposed on the surface of apoptotic cells, and promotes their phagocytic uptake by TIM1-expressing cells. Together, our data show that PE plays a key role in TIM1-mediated virus entry, suggest that disrupting PE association with PS receptors is a promising broad-spectrum antiviral strategy, and deepen our understanding of the process by which apoptotic cells are cleared.

Indexed as

AnimalsApoptosisBacteriocinsDengueDengue VirusEbolavirusHemorrhagic Fever, EbolaHepatitis A Virus Cellular Receptor 1HumansJurkat CellsLigandsMembrane GlycoproteinsMembranesMicePeptidesPhagocytosisBacteriocinsduramycinHAVCR1 protein, humanHepatitis A Virus Cellular Receptor 1LigandsMembrane GlycoproteinsPeptidesphosphatidylethanolaminePhosphatidylethanolaminesphosphatidylserine receptorReceptors, Cell SurfaceReceptors, Virusapoptotic mimicryphosphatidylethanolaminephosphatidylserine receptorsT-cell immunoglobulin mucin domain proteinsvirus entry

Identifiers

PMID26575624
PMCPMC4664333
OpenAlexW1931440368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.